Enhabit (NYSE:EHAB) Issues Quarterly Earnings Results, Hits Estimates

Enhabit (NYSE:EHAB) released its quarterly earnings results on Wednesday. The company reported $0.14 earnings per share for the quarter, meeting the consensus estimate of $0.14, FiscalAI reports. The firm had revenue of $270.40 million for the quarter, compared to analysts’ expectations of $270.56 million. Enhabit had a positive return on equity of 3.91% and a negative net margin of 1.14%.

Enhabit Trading Down 0.1%

Shares of EHAB stock traded down $0.01 on Thursday, hitting $13.60. 352,008 shares of the company’s stock traded hands, compared to its average volume of 1,280,904. The stock has a market capitalization of $688.30 million, a price-to-earnings ratio of -54.40 and a beta of 1.56. The company’s fifty day simple moving average is $10.96 and its 200 day simple moving average is $9.30. Enhabit has a one year low of $6.47 and a one year high of $13.64. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.58 and a current ratio of 1.58.

Analysts Set New Price Targets

Several research analysts recently weighed in on EHAB shares. Wolfe Research set a $12.00 price objective on shares of Enhabit in a research report on Thursday, January 8th. TD Cowen raised shares of Enhabit to a “buy” rating in a research note on Tuesday, January 13th. Citigroup restated a “buy” rating on shares of Enhabit in a research report on Tuesday, December 16th. Leerink Partners lifted their price objective on shares of Enhabit from $9.50 to $13.80 and gave the stock a “market perform” rating in a report on Monday, February 23rd. Finally, UBS Group reissued a “neutral” rating and issued a $13.80 target price (up from $12.00) on shares of Enhabit in a research note on Tuesday, February 24th. Three research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $13.31.

Institutional Trading of Enhabit

Institutional investors have recently added to or reduced their stakes in the business. Arrowstreet Capital Limited Partnership increased its holdings in shares of Enhabit by 96.5% in the second quarter. Arrowstreet Capital Limited Partnership now owns 640,074 shares of the company’s stock worth $6,170,000 after buying an additional 314,401 shares during the period. Marshall Wace LLP boosted its holdings in Enhabit by 59.2% during the 3rd quarter. Marshall Wace LLP now owns 792,981 shares of the company’s stock valued at $6,352,000 after acquiring an additional 294,999 shares during the period. Bank of America Corp DE grew its position in Enhabit by 73.3% during the 3rd quarter. Bank of America Corp DE now owns 687,934 shares of the company’s stock worth $5,510,000 after acquiring an additional 290,978 shares during the last quarter. Vanguard Group Inc. increased its stake in Enhabit by 8.2% in the 3rd quarter. Vanguard Group Inc. now owns 3,393,069 shares of the company’s stock worth $27,178,000 after purchasing an additional 256,559 shares during the period. Finally, Lazard Asset Management LLC increased its stake in Enhabit by 245.6% in the 3rd quarter. Lazard Asset Management LLC now owns 297,920 shares of the company’s stock worth $2,386,000 after purchasing an additional 211,720 shares during the period.

About Enhabit

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.